| Literature DB >> 32407418 |
Li Zhang1, Mengya Yuan1, Zhen An1, Xiangmei Zhao1, Hui Wu1, Haibin Li1, Ya Wang1, Beibei Sun1, Huijun Li1, Shibin Ding1, Xiang Zeng1, Ling Chao1, Pan Li1, Weidong Wu1.
Abstract
Retinal fundus photography provides a non-invasive approach for identifying early microcirculatory alterations of chronic diseases prior to the onset of overt clinical complications. Here, we developed neural network models to predict hypertension, hyperglycemia, dyslipidemia, and a range of risk factors from retinal fundus images obtained from a cross-sectional study of chronic diseases in rural areas of Xinxiang County, Henan, in central China. 1222 high-quality retinal images and over 50 measurements of anthropometry and biochemical parameters were generated from 625 subjects. The models in this study achieved an area under the ROC curve (AUC) of 0.880 in predicting hyperglycemia, of 0.766 in predicting hypertension, and of 0.703 in predicting dyslipidemia. In addition, these models can predict with AUC>0.7 several blood test erythrocyte parameters, including hematocrit (HCT), mean corpuscular hemoglobin concentration (MCHC), and a cluster of cardiovascular disease (CVD) risk factors. Taken together, deep learning approaches are feasible for predicting hypertension, dyslipidemia, diabetes, and risks of other chronic diseases.Entities:
Year: 2020 PMID: 32407418 PMCID: PMC7224473 DOI: 10.1371/journal.pone.0233166
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of 625 subjects in our chronic disease cohort dataset.
| Characteristics | Datasets | Characteristics | Datasets | Characteristics | Datasets |
|---|---|---|---|---|---|
| Age: mean, years (s. d.) | 54.70(11.67), n = 625 | Indirect bilirubin: mean, μmol/L (s. d.) | 12.59(5.99), n = 623 | MO#: mean, 109/L (s. d.) | 0.33(0.11), n = 615 |
| Gender (% male) | 39.7, n = 625 | ALT: mean, U/L (s. d.) | 23.33(24.52), n = 624 | EO#: mean, 109/L (s. d.) | 0.12(0.11), n = 614 |
| Current Smoker: % | 41.19%, n = 624 | Alkaline phosphatase: mean, U/L (s. d.) | 88.67(26.21), n = 624 | BASO#: mean, 109/L (s. d.) | 0.03(0.02), n = 614 |
| Drinking: % | 26.60%, n = 624 | AST: mean, U/L (s. d.) | 23.16(14.08), n = 624 | RBC: mean, 1012/L (s. d.) | 4.82(0.47), n = 615 |
| Moderate exercise: % | 90.24, n = 625 | Creatinine: mean, μmol/L (s. d.) | 61.13(12.82), n = 624 | Hematocrit: mean, % (s. d.) | 44.61(4.69), n = 615 |
| Salty Taste: % | 23.40, n = 624 | Urea: mean, mmol/L (s. d.) | 4.90(1.32), n = 624 | MCV: mean, fL (s. d.) | 92.64(6.87), n = 616 |
| PSQI: mean, (s. d.) | 3.84(2.73), n = 619 | Uric acid: mean, μmol/L (s. d.) | 280.85(82.18), n = 624 | MCH: mean, pg (s. d.) | 29.25(2.12), n = 616 |
| Body mass index: mean, kg/m2 (s. d.) | 25.59(3.45), n = 624 | Total cholesterol: mean, mmol/L (s. d.) | 5.32(1.06), n = 624 | MCHC: mean, g/L (s. d.) | 316.28(17.50), n = 616 |
| Basal metabolism: mean, kcal (s. d.) | 1427.96(219.76), n = 624 | Triglyceride: mean, mmol/L (s. d.) | 1.72(1.26), n = 623 | Hemoglobin: mean, g/L (s. d.) | 141.09(16.44), n = 615 |
| Waist-hip ratio: mean, (s. d.) | 0.89(0.07), n = 624 | LDL-C: mean, mmol/L (s. d.) | 2.95(0.78), n = 624 | RDW-CV: mean, % (s. d.) | 13.50(1.33), n = 615 |
| Body fat ratio: mean, % (s. d.) | 31.05(6.51), n = 624 | HDL-C: mean, mmol/L (s. d.) | 1.34(0.34), n = 624 | RDW-SD: mean, fL (s. d.) | 44.56(4.91), n = 616 |
| Visceral fat index: mean, (s. d.) | 10.07(4.40), n = 625 | FPG: mean, mmol/L (s. d.) | 6.01(1.59), n = 624 | MPV: mean, fL (s. d.) | 11.05(0.97), n = 615 |
| Current chronic disease: % | 55.86, n = 623 | Glycated hemoglobin: mean, % (s. d.) | 5.61(1.03), n = 612 | PLT: mean, 109/L (s. d.) | 249.90(64.24), n = 615 |
| Systolic BP: mean, mmHg (s. d.) | 133.02(20.02), n = 625 | Insulin: mean, μU/L (s. d.) | 8.77(7.17), n = 623 | Plateletcrit: mean, % (s. d.) | 0.27(0.07), n = 613 |
| Diastolic BP: mean, mmHg (s. d.) | 84.11(11.42), n = 625 | White blood cell count: mean, 109/L (s. d.) | 6.06(1.46), n = 615 | PDW: mean, % (s. d.) | 12.63(2.03), n = 614 |
| Total bilirubin: mean, μmol/L (s. d.) | 16.61(7.43), n = 623 | NEUT#: mean, 109/L (s. d.) | 3.55(1.15), n = 614 | P-LCR: mean, % (s. d.) | 46.32(2.32), n = 615 |
| Direct bilirubin: mean, μmol/L (s. d.) | 4.02(1.63), n = 624 | Lymphocyte count: mean, 109/L (s. d.) | 2.03(0.57), n = 615 |
n is the number of subjects for whom that measurement was available.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BASO#, basophil absolute count; BP, blood pressure; EO#, eosinophil absolute count; FPG, Fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; MO#, monocytes absolute count; MPV, mean platelet volume; NEUT#, neutrophil absolute count; PDW, platelet distribution width; P-LCR, platelet large cell ratio; PLT, platelet concentration; PSQI, pittsburgh sleep quality index; RBC, red blood cell count; RDW-CV, red blood cell distribution width-coefficient of variation; RDW-SD, red blood cell distribution width-standard deviation.
Classification criterion and the model performance of each variable.
| Risk factors used for the prediction | Status or cutoff value | Prediction accuracy (%) | AUC |
|---|---|---|---|
| Age | >55 | 0.748 | 0.850 |
| Gender | Male/Female | 0.624 | 0.704 |
| Drinking | Drinkers/non-drinkers | 0.863 | 0.948 |
| Salty Taste | High-salt diet/lower-salt diet | 0.757 | 0.809 |
| Smoking | Smoker/non-smoker | 0.732 | 0.794 |
| BMI | ≦24.0 kg/m2 | 0.712 | 0.731 |
| WHR | Male<0.9, Female<0.85 | 0.646 | 0.704 |
| HCT | Male 40–50%, Female 35–45% | 0.698 | 0.759 |
| MCHC | 316–354 g/L | 0.605 | 0.686 |
| T-BIL | 3.4–17.1 μmol/L | 0.700 | 0.764 |
| D-BIL | 0–3.4 μmol/L | 0.650 | 0.703 |
Abbreviation: BMI, body mass index; BP, blood pressure; D-BIL, direct bilirubin; HCT, hematocrit; MCHC, mean corpuscular hemoglobin concentration; T-BIL, total bilirubin; WHR, waist-hip ratio